Text Size

Trial of Impact of Crime Group Intervention for Jail Inmates (IOC-1)

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
National Institute on Drug Abuse (NIDA)
Information provided by (Responsible Party):
June Tangney, George Mason University
ClinicalTrials.gov Identifier:
NCT01380977
First received: June 21, 2011
Last updated: May 3, 2013
Last verified: May 2013
History of Changes
  Purpose

This pilot study is designed to evaluate the efficacy of the Impact of Crime (IOC) group intervention for jail inmates. The hypothesis is that participants in IOC will show decreases in criminogenic thinking, decreases in shame, increases in guilt, and increases in empathy, which in turn will be reflected in reduced recidivism (official records and self report), relative to those randomly assigned to a treatment as usual group.


Condition Intervention Phase
Crime
Substance Abuse
HIV Risk
Criminogenic Thinking
Shame
 Behavioral: Impact of Crime group intervention
 Phase 1
Phase 2

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double Blind (Investigator, Outcomes Assessor)
Primary Purpose: Treatment

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by George Mason University:

Primary Outcome Measures:
  • Self reported recidivism (arrests and undetected offenses) [ Time Frame: 1 year post-release up to 2 yrs post release ] [ Designated as safety issue: No ]
  • Self reported recidivism (arrests and undetected offenses) [ Time Frame: 4 years post-release up to 5 yrs post release ] [ Designated as safety issue: No ]
  • Self reported recidivism (arrests and undetected offenses) [ Time Frame: 7 years post-release up to 8 yrs post-release ] [ Designated as safety issue: No ]
  • Self reported recidivism (arrests and undetected offenses) [ Time Frame: 10 years post-release up to 11 yrs post-release ] [ Designated as safety issue: No ]
  • Self-reported Substance Use and Dependence - TCU [ Time Frame: 1 year post-release up to 2 yrs post-release ] [ Designated as safety issue: No ]
  • Self-reported Substance Use and Dependence - TCU [ Time Frame: 4 years post-release up to 5 yrs post-release ] [ Designated as safety issue: No ]
  • Self-reported Substance Use and Dependence - TCU [ Time Frame: 7 years post-release up to 8 yrs post-release ] [ Designated as safety issue: No ]
  • Self-reported Substance Use and Dependence - TCU [ Time Frame: 10 years post-release up to 11 yrs post release ] [ Designated as safety issue: No ]
  • Self-reported HIV risk behaviors (sex and IDU) - TCU [ Time Frame: 1 year post-release - up to 2 yrs post-release ] [ Designated as safety issue: No ]
  • Self-reported HIV risk behaviors (sex and IDU) - TCU [ Time Frame: 4 years post-release up to 5 yrs post-release ] [ Designated as safety issue: No ]
  • Self-reported HIV risk behaviors (sex and IDU) - TCU [ Time Frame: 7 years post-release up to 8 yrs post-release ] [ Designated as safety issue: No ]
  • Self-reported HIV risk behaviors (sex and IDU) - TCU [ Time Frame: 10 years post-release up to 11 yrs post-release ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Changes from baseline in Self reported criminogenic beliefs - CCS [ Time Frame: Baseline to post-treatment up to 9 mos ] [ Designated as safety issue: No ]
  • Changes from baseline in Self reported criminogenic beliefs - CCS [ Time Frame: Baseline to pre-release up to 1.5 yrs ] [ Designated as safety issue: No ]
  • Changes from baseline in Self reported criminogenic beliefs - CCS [ Time Frame: Baseline to 1 yr post-release up to 3.5 yrs ] [ Designated as safety issue: No ]
  • Changes from baseline in Self reported criminogenic beliefs - CCS [ Time Frame: Baseline to 4 yrs post-release up to 6.5 yrs ] [ Designated as safety issue: No ]
  • Changes from baseline in Self reported criminogenic beliefs - CCS [ Time Frame: Baseline to 7 yrs post-release up 9,5 yrs ] [ Designated as safety issue: No ]
  • Changes from baseline in Self reported criminogenic beliefs - CCS [ Time Frame: Baseline to 10 yrs post-release up to 12.5 yrs ] [ Designated as safety issue: No ]
  • Changes from baseline in self-reported shame - TOSCA-SD [ Time Frame: Baseline to post-treatment up to 9 mos ] [ Designated as safety issue: No ]
  • Changes from baseline in self-reported shame - TOSCA-SD [ Time Frame: Baseline to pre-release up to 1.5 yrs ] [ Designated as safety issue: No ]
  • Changes from baseline in self-reported shame - TOSCA-SD [ Time Frame: Baseline to 1 yr post release up to 3.5 yrs ] [ Designated as safety issue: No ]
  • Changes from baseline in self-reported shame - TOSCA-SD [ Time Frame: Baseline to 4 yrs post release up to 6.5 yrs ] [ Designated as safety issue: No ]
  • Changes from baseline in self-reported shame - TOSCA-SD [ Time Frame: Baseline to 7 yrs post release up to 9.5 yrs ] [ Designated as safety issue: No ]
  • Changes from baseline in self-reported shame - TOSCA-SD [ Time Frame: Baseline to 10 yrs post release up to 12.5 yrs ] [ Designated as safety issue: No ]
  • Changes from baseline in self-reported Guilt - TOSCA-SD [ Time Frame: Baseline to post-treatment up to 9 mos ] [ Designated as safety issue: No ]
  • Changes from baseline in self-reported Guilt - TOSCA-SD [ Time Frame: Baseline to pre-release up to 1.5 yrs ] [ Designated as safety issue: No ]
  • Changes from baseline in self-reported Guilt - TOSCA-SD [ Time Frame: Baseline to 1 yr post-release up to 3.5 yrs ] [ Designated as safety issue: No ]
  • Changes from baseline in self-reported Guilt - TOSCA-SD [ Time Frame: Baseline to 4 yrs post-release up to 6.5 yrs ] [ Designated as safety issue: No ]
  • Changes from baseline in self-reported Guilt - TOSCA-SD [ Time Frame: Baseline to 7 yrs post-release up to 9.5 yrs ] [ Designated as safety issue: No ]
  • Changes from baseline in self-reported Guilt - TOSCA-SD [ Time Frame: Baseline to 10 yrs post-release up to 12.5 yrs ] [ Designated as safety issue: No ]
  • Changes from baseline in self-reported Empathy - IRI [ Time Frame: Baseline to post-treatment up to 9 mos ] [ Designated as safety issue: No ]
  • Changes from baseline in self-reported Empathy - IRI [ Time Frame: Baseline to pre-release up to 1.5 yrs ] [ Designated as safety issue: No ]
  • Changes from baseline in self-reported Empathy - IRI [ Time Frame: Baseline to 1 year post-release up to 3.5 yrs ] [ Designated as safety issue: No ]
  • Changes from baseline in self-reported Empathy - IRI [ Time Frame: Baseline to 4 years post-release up to 6.5 yrs ] [ Designated as safety issue: No ]
  • Changes from baseline in self-reported Empathy - IRI [ Time Frame: Baseline to 7 years post-release up to 9.5 yrs ] [ Designated as safety issue: No ]
  • Changes from baseline in self-reported Empathy - IRI [ Time Frame: Baseline to 10 years post-release up to 12.5 yrs ] [ Designated as safety issue: No ]

Enrollment: 51
Study Start Date: August 2002
Estimated Study Completion Date: July 2016
Estimated Primary Completion Date: August 2013 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Impact of Crime group intervention Behavioral: Impact of Crime group intervention
A group intervention for 16 1.5 hr sessions held twice a week
Active Comparator: Treatment as usual Behavioral: Impact of Crime group intervention
A group intervention for 16 1.5 hr sessions held twice a week

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Male
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Must be 18 years or older
  • Must be male
  • Must be currently incarcerated jail inmate
  • Must be sentenced
  • Must speak, read, and write in English with sufficient proficiency to use workbook and participate in group sessions
  • Must be assigned to the jail's "general population"

Exclusion Criteria:

  • Actively psychotic
  • Assigned "keep separate" from other group members
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01380977

Locations
United States, Virginia
Fairfax County Adult Detention Center
Fairfax, Virginia, United States, 22030
Sponsors and Collaborators
George Mason University
National Institute on Drug Abuse (NIDA)
Investigators
Principal Investigator: June P Tangney, Ph.D. George Mason University
  More Information

No publications provided

Responsible Party: June Tangney, Professor, George Mason University
ClinicalTrials.gov Identifier: NCT01380977     History of Changes
Other Study ID Numbers: R01DA014694-1, R01DA014694
Study First Received: June 21, 2011
Last Updated: May 3, 2013
Health Authority: United States: Institutional Review Board

Keywords provided by George Mason University:
crime
substance abuse
HIV risk
criminogenic thinking
 shame
guilt
restorative justice
victim impact group

Additional relevant MeSH terms:
Substance-Related Disorders
Mental Disorders

ClinicalTrials.gov processed this record on June 13, 2013